We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

253 hedge funds and large institutions have $20.4B invested in BeOne Medicines Ltd in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 79 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 79

7% more capital invested

Capital invested by funds: $19.1B → $20.4B (+$1.32B)

0.01% more ownership

Funds ownership: 4.65% → 4.67% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 11 → 11 (0)

5% less funds holding

Funds holding: 266 → 253 (-13)

24% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 37

32% less call options, than puts

Call options by funds: $31.3M | Put options by funds: $46M

Holders
253
Holders Change
-13
Holders Change %
-4.89%
% of All Funds
4.43%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
28
Increased
97
Reduced
79
Closed
37
Calls
$31.3M
Puts
$46M
Net Calls
-$14.7M
Net Calls Change
-$13.4M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$190M
2
PIF
Public Investment Fund
Saudi Arabia
+$162M
3
Capital International Investors
Capital International Investors
California
+$126M
4
Norges Bank
Norges Bank
Norway
+$108M
5
Temasek Holdings
Temasek Holdings
Singapore
+$54.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$156M
2
RSCM
Rock Springs Capital Management
Maryland
-$68.6M
3
AG
Artal Group
Luxembourg
-$65.4M
4
CBT
Capital Bank & Trust
California
-$53.7M
5
DCM
Driehaus Capital Management
Illinois
-$52.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
WFI
276
West Family Investments
California
– -$422K -1,231 Closed
YIH
277
Y-Intercept (HK)
Hong Kong
– -$323K -940 Closed
EVM
278
Eaton Vance Management
Massachusetts
– -$270K -789 Closed
Two Sigma Advisers
279
Two Sigma Advisers
New York
– -$240K -700 Closed
VWM
280
Vigilare Wealth Management
Arizona
– -$233K -680 Closed
CGIM
281
Cannon Global Investment Management
Florida
– -$206K -600 Closed
Group One Trading
282
Group One Trading
Illinois
– -$151K -463 Closed
EFSCE
283
Enterprise Financial Services Corp (EFSC)
Missouri
– -$13K -39 Closed
RE
284
RBC Europe
United Kingdom
– -$13K -38 Closed
SL
285
Savior LLC
Massachusetts
– -$5K -15 Closed
MCM
286
Manchester Capital Management
Vermont
– -$4K -11 Closed
PVH
287
Psagot Value Holdings
Israel
– -$1K -4 Closed
ASN
288
Advisory Services Network
Georgia
– -$1K -3 Closed
GWS
289
Glassman Wealth Services
Virginia
– +$327 +1 New
8 9 10 11
12

ONC Hedge Fund Activity: Q3 2021 in Review

253 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2021, worth a combined $20.4B — up 6.9% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of ONC and 28 opened new positions — a net loss of 9 holders — while 79 trimmed existing stakes and 97 added.

The largest buyer was Invesco, adding an estimated $190M. The largest seller was Fidelity Investments, cutting an estimated $156M.

  • 253 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2021, down from 266 in Q2 2021.
  • Funds reported $20.4B of BeOne Medicines Ltd stock for Q3 2021, up 6.9% quarter-over-quarter.
  • 28 funds opened new BeOne Medicines Ltd positions in Q3 2021 and 37 closed out, a net change of -9 holders.
  • The largest BeOne Medicines Ltd buyer in Q3 2021 was Invesco, an estimated $190M added.
  • The largest BeOne Medicines Ltd seller in Q3 2021 was Fidelity Investments, an estimated $156M sold.

Based on aggregated 13F filings for Q3 2021.